AGN 4.05% 77.0¢ argenica therapeutics limited

ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-4

  1. 34,345 Posts.
    lightbulb Created with Sketch. 9131
    I watched the interview.
    It's interesting, but it is still way too early as it's on pre-clinical stage.
    It would take another 8 years to complete 3 phase trials providing no failures on every phase.
    I don't think many IPO subscribers would wait that long, just take profit and run, imo.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.